Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001510281-25-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-02-05 | 2025-02-03+ | HQL | Weinstein Boaz | 10% | S - Sale | $14.04 | -5,911 | 3.38M | -0.2% | -$83.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | S | D | 4,065 | $14.05 | 3,375,460 | I - | — | — | |
| 2 | Common | Common Stock | 2025-02-03 | S | D | 1,846 | $14.03 | 3,379,525 | I - | — | — |